NOD2 signaling and role in pathogenic Mycobacterium recognition, infection and immunity

Cellular Physiology and Biochemistry

Volumn 30, Issue 4, 2012, Pages 953-963

  Deng, Wanyan ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Innate immune; Mycobacterium tuberculosis; NOD2; Sentinel; Tuberculosis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BACTERICIDAL ACTIVITY; CROHN DISEASE; HUMAN; INNATE IMMUNITY; LEPROSY; MACROPHAGE ACTIVATION; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84866168097     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341472     Document Type: Review

References (78)

1. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ: Human toll-like receptors mediate cellular activation by mycobacterium tuberculosis. J Immunol 1999;163:3920-3927. (Pubitemid 29450920)
2. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, Goyert S, Ehlers S: Cutting edge: Tolllike receptor (tlr) 2-and tlr4-mediated pathogen recognition in resistance to airborne infection with mycobacterium tuberculosis. J Immunol 2002;169:3480-3484.
3. Ferwerda G, Girardin SE, Kullberg BJ, Le Bourhis L, De Jong DJ, Langenberg DM, Van Crevel R, Adema GJ, Ottenhoff TH, Van der Meer JW, Netea MG: Nod2 and toll-like receptors are nonredundant recognition systems of mycobacterium tuberculosis. PLoS Pathog 2005;1:279-285.
4. Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG, Nunez G: Intracellular nod-like receptors in innate immunity, infection and disease. Cell Microbiol 2008;10:1-8. (Pubitemid 350239051)
5. Kanneganti TD, Lamkanfi M, Nunez G: Intracellular nod-like receptors in host defense and disease. Immunity 2007;27:549-559. (Pubitemid 47615512)
6. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G: Host recognition of bacterial muramyl dipeptide mediated through nod2. Implications for crohns disease. J Biol Chem 2003;278:5509-5512. (Pubitemid 36800790)
7. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of nod2 leucine-rich repeat variants with susceptibility to crohns disease. Nature 2001;411:599-603. (Pubitemid 32531408)
8. Aaron M, Charbon G, Lam H, Schwarz H, Vollmer W, Jacobs-Wagner C: The tubulin homologue ftsz contributes to cell elongation by guiding cell wall precursor synthesis in caulobacter crescentus. Mol Microbiol 2007;64:938-952. (Pubitemid 46743973)
9. Yang S, Tamai R, Akashi S, Takeuchi O, Akira S, Sugawara S, Takada H: Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect Immun 2001;69:2045-2053. (Pubitemid 32239668)
10. Dubytska L, Godfrey HP, Cabello FC: Borrelia burgdorferi ftsz plays a role in cell division. J Bacteriol 2006;188:3430.
11. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G: Nod2, a nod1/apaf-1 family member that is restricted to monocytes and activates nf-kappab. J Biol Chem 2001;276:4812-4818.
12. Brooks MN, Rajaram MV, Azad AK, Amer AO, Valdivia-Arenas MA, Park JH, Nunez G, Schlesinger LS: Nod2 controls the nature of the inflammatory response and subsequent fate of mycobacterium tuberculosis and m. Bovis bcg in human macrophages. Cell Microbiol 2011;13:402-418.
13. Gandotra S, Jang S, Murray PJ, Salgame P, Ehrt S: Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with mycobacterium tuberculosis. Infect Immun 2007;75:5127-5134. (Pubitemid 350033599)
14. Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, Veyrier F, Kobayashi KS, Flavell RA, Gros P, Behr MA: Nod2-deficient mice have impaired resistance to mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 2008;181:7157-7165.
15. Juarez E, Carranza C, Hernandez-Sanchez F, Leon-Contreras JC, Hernandez-Pando R, Escobedo D, Torres M, Sada E: Nod2 enhances the innate response of alveolar macrophages to mycobacterium tuberculosis in humans. Eur J Immunol 2012;42:880-889.
16. Hermon-Taylor J: Mycobacterium avium subspecies paratuberculosis, crohns disease and the doomsday scenario. Gut Pathog 2009;1:15.
17. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, Cui Y, Yan XX, Yang HT, Yang RD, Chu TS, Zhang C, Zhang L, Han JW, Yu GQ, Quan C, Yu YX, Zhang Z, Shi BQ, Zhang LH, Cheng H, Wang CY, Lin Y, Zheng HF, Fu XA, Zuo XB, Wang Q, Long H, Sun YP, Cheng YL, Tian HQ, Zhou FS, Liu HX, Lu WS, He SM, Du WL, Shen M, Jin QY, Wang Y, Low HQ, Erwin T, Yang NH, Li JY, Zhao X, Jiao YL, Mao LG, Yin G, Jiang ZX, Wang XD, Yu JP, Hu ZH, Gong CH, Liu YQ, Liu RY, Wang DM, Wei D, Liu JX, Cao WK, Cao HZ, Li YP, Yan WG, Wei SY, Wang KJ, Hibberd ML, Yang S, Zhang XJ, Liu JJ: Genomewide association study of leprosy. N Engl J Med 2009;361:2609-2618.
18. Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, Kelliher MA: Nod2 pathway activation by mdp or mycobacterium tuberculosis infection involves the stable polyubiquitination of rip2. J Biol Chem 2007;282:36223-36229.
19. Harton JA, Linhoff MW, Zhang J, Ting JP: Cutting edge: Caterpiller: A large family of mammalian genes containing card, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 2002;169:4088-4093. (Pubitemid 35178175)
20. Inohara N, Nunez G: Nods: Intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 2003;3:371-382. (Pubitemid 37323197)
21. Ting JP, Davis BK: Caterpiller: A novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 2005;23:387-414. (Pubitemid 40563175)
22. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL: Induction of nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa b activation. J Biol Chem 2002;277:41701-41705. (Pubitemid 35257477)
23. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK: Card15/nod2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000. (Pubitemid 36389802)
24. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S: Tnf-alpha and ifn-gamma regulate the expression of the nod2 (card15) gene in human intestinal epithelial cells. Gastroenterology 2003;124:1001-1009. (Pubitemid 36389803)
25. Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cezard JP, Zouali H, Emilie D, Peuchmaur M: Card15 gene overexpression in mononuclear and epithelial cells of the inflamed crohns disease colon. Gut 2003;52:840-846. (Pubitemid 36613491)
26. Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK: Membrane recruitment of nod2 in intestinal epithelial cells is essential for nuclear factor-{kappa}b activation in muramyl dipeptide recognition. J Cell Biol 2005;170:21-26. (Pubitemid 40994092)
27. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (mdp) detection. J Biol Chem 2003;278:8869-8872. (Pubitemid 36800360)
28. Akira S, Takeda K, Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680. (Pubitemid 32747155)
29. Aderem A, Ulevitch RJ: Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-787.
30. Abdallah AM, Gey Van Pittius NC, Champion PA, Cox J, Luirink J, Vandenbroucke-Grauls CM, Appelmelk BJ, Bitter W: Type VII secretion-mycobacteria show the way. Nat Rev Microbiol 2007;5:883-891. (Pubitemid 47578389)
31. Ganguly N, Giang PH, Gupta C, Basu SK, Siddiqui I, Salunke DM, Sharma P: Mycobacterium tuberculosis secretory proteins cfp-10, esat-6 and the cfp10:Esat6 complex inhibit lipopolysaccharide-induced nfkappab transactivation by downregulation of reactive oxidative species (ros) production. Immunol Cell Biol 2008;86:98-106.
32. Simeone R, Bottai D, Brosch R: Esx/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 2009;12:4-10.
33. Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, Brown EJ: A mycobacterial virulence gene cluster extending rd1 is required for cytolysis, bacterial spreading and esat-6 secretion. Mol Microbiol 2004;53:1677-1693. (Pubitemid 39265314)
34. De Jonge MI, Pehau-Arnaudet G, Fretz MM, Romain F, Bottai D, Brodin P, Honore N, Marchal G, Jiskoot W, England P, Cole ST, Brosch R: Esat-6 from mycobacterium tuberculosis dissociates from its putative chaperone cfp-10 under acidic conditions and exhibits membrane-lysing activity. J Bacteriol 2007;189:6028-6034. (Pubitemid 47236155)
35. Stanley SA, Johndrow JE, Manzanillo P, Cox JS: The type I ifn response to infection with mycobacterium tuberculosis requires esx-1-mediated secretion and contributes to pathogenesis. J Immunol 2007;178:3143-3152. (Pubitemid 46333196)
36. Koo IC, Ohol YM, Wu P, Morisaki JH, Cox JS, Brown EJ: Role for lysosomal enzyme beta-hexosaminidase in the control of mycobacteria infection. Proc Natl Acad Sci U S A 2008;105:710-715. (Pubitemid 351171773)
37. Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, Behr MA, Fitzgerald KA, Sassetti CM, Kelliher MA: Nod2, rip2 and irf5 play a critical role in the type I interferon response to mycobacterium tuberculosis. PLoS Pathog 2009;5:e1000500.
38. Girardin SE, Travassos LH, Herve M, Blanot D, Boneca IG, Philpott DJ, Sansonetti PJ, Mengin-Lecreulx D: Peptidoglycan molecular requirements allowing detection by nod1 and nod2. J Biol Chem 2003;278:41702-41708. (Pubitemid 37310428)
39. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nunez G, Inohara N: A critical role of rick/rip2 polyubiquitination in nod-induced nf-kappab activation. EMBO J 2008;27:373-383. (Pubitemid 351161652)
40. Boneca IG: The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 2005;8:46-53. (Pubitemid 40203225)
41. Cloud-Hansen KA, Peterson SB, Stabb EV, Goldman WE, McFall-Ngai MJ, Handelsman J: Breaching the great wall: Peptidoglycan and microbial interactions. Nat Rev Microbiol 2006;4:710-716.
42. Mengin-Lecreulx D, Lemaitre B: Structure and metabolism of peptidoglycan and molecular requirements allowing its detection by the drosophila innate immune system. J Endotoxin Res 2005;11:105-111. (Pubitemid 40711486)
43. Lenfant M, Hunt PF, Therier LM, Pinte F, Lederer E: [n-methylations of aniline by mycobacterium tuberculosis]. Biochim Biophys Acta 1970;201:82-90.
44. Petit J, Adam A, Wietzerbin-Falszpan J: Isolation of udp-n- glycolylmuramyl-(ala, glu, dap) from mycobacterium phlei. FEBS Lett 1970;6:55-57.
45. Azuma I, Thomas DW, Adam A, Ghuysen JM, Bonaly R, Petit JF, Lederer E: Occurrence of n-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta 1970;208:444-451.
46. Raymond JB, Mahapatra S, Crick DC, Pavelka MS Jr: Identification of the namh gene, encoding the hydroxylase responsible for the n-glycolylation of the mycobacterial peptidoglycan. J Biol Chem 2005;280:326-333. (Pubitemid 40164996)
47. Coulombe F, Divangahi M, Veyrier F, De Leseleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA: Increased nod2-mediated recognition of n-glycolyl muramyl dipeptide. J Exp Med 2009;206:1709-1716.
48. Schmeck B, Zahlten J, Moog K, Van Laak V, Huber S, Hocke AC, Opitz B, Hoffmann E, Kracht M, Zerrahn J, Hammerschmidt S, Rosseau S, Suttorp N, Hippenstiel S: Streptococcus pneumoniae-induced p38 mapkdependent phosphorylation of rela at the interleukin-8 promotor. J Biol Chem 2004;279:53241-53247. (Pubitemid 40051827)
49. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA: Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-734. (Pubitemid 40194644)
50. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, Medzhitov R, Flavell RA: Rick/rip2/cardiak mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002;416:194-199. (Pubitemid 34246479)
51. Watanabe T, Kitani A, Murray PJ, Strober W: Nod2 is a negative regulator of toll-like receptor 2-mediated t helper type 1 responses. Nat Immunol 2004;5:800-808. (Pubitemid 39172973)
52. Abbott DW, Wilkins A, Asara JM, Cantley LC: The crohns disease protein, nod2, requires rip2 in order to induce ubiquitinylation of a novel site on nemo. Curr Biol 2004;14:2217-2227. (Pubitemid 40033358)
53. Zhou H, Wertz I, O'Rourke K, Ultsch M, Seshagiri S, Eby M, Xiao W, Dixit VM: Bcl10 activates the nf-kappab pathway through ubiquitination of nemo. Nature 2004;427:167-171. (Pubitemid 38094958)
54. Barnich N, Hisamatsu T, Aguirre JE, Xavier R, Reinecker HC, Podolsky DK: Grim-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem 2005;280:19021-19026. (Pubitemid 41379607)
55. Pauleau AL, Murray PJ: Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol Cell Biol 2003;23:7531-7539. (Pubitemid 37271454)
56. Hsu YM, Zhang Y, You Y, Wang D, Li H, Duramad O, Qin XF, Dong C, Lin X: The adaptor protein card9 is required for innate immune responses to intracellular pathogens. Nat Immunol 2007;8:198-205. (Pubitemid 46152651)
57. Damiano JS, Oliveira V, Welsh K, Reed JC: Heterotypic interactions among nacht domains: Implications for regulation of innate immune responses. Biochem J 2004;381:213-219. (Pubitemid 38932227)
58. Martinon F, Tschopp J: Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-574. (Pubitemid 38692523)
59. Rodriguez-Perez N, Aguinaga-Barrilero A, Gorrono-Echebarria MB, Perez-Blas M, Martin-Villa JM: Blau syndrome-related card15/nod2 mutations are not linked to idiopathic uveitis in spanish patients. Dis Markers 2009;27:1-5.
60. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP: Card15 mutations in blau syndrome. Nat Genet 2001;29:19-20. (Pubitemid 32801800)
61. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y: Early-onset sarcoidosis and card15 mutations with constitutive nuclear factor-kappab activation: Common genetic etiology with blau syndrome. Blood 2005;105:1195-1197. (Pubitemid 40170893)
62. Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D, Hilgendorf I, Hahn J, Edinger M, Hoffmann P, Obermeier F, Schoelmerich J, Andreesen R, Holler E: Recipient nod2/card15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin Exp Immunol 2010;159:87-92.
63. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J, Eissner G, Scholmerich J, Andreesen R: Both donor and recipient nod2/card15 mutations associate with transplant-related mortality and gvhd following allogeneic stem cell transplantation. Blood 2004;104:889-894. (Pubitemid 38970589)
64. Austin CM, Ma X, Graviss EA: Common nonsynonymous polymorphisms in the nod2 gene are associated with resistance or susceptibility to tuberculosis disease in african americans. J Infect Dis 2008;197:1713-1716. (Pubitemid 351919636)
65. Kang TJ, Lee GS, Kim SK, Jin SH, Chae GT: Comparison of two mice strains, a/j and c57bl/6, in caspase-1. activity and il-1beta secretion of macrophage to mycobacterium leprae infection. Mediators Inflamm 2010;2010:708713.
66. Kang TJ, Yeum CE, Kim BC, You EY, Chae GT: Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a toll-like receptor 2 mutation. Immunology 2004;112:674-680.
67. Kang TJ, Chae GT: The role of intracellular receptor nods for cytokine production by macrophages infected with mycobacterium leprae. Immune Netw 2011;11:424-427.
68. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G: Mapping of a susceptibility locus for crohns disease on chromosome 16. Nature 1996;379:821-823. (Pubitemid 26067722)
69. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in nod2 associated with susceptibility to crohns disease. Nature 2001;411:603-606. (Pubitemid 32531409)
70. Tiruviluamala P, Reichman LB: Tuberculosis. Annu Rev Public Health 2002;23:403-426. (Pubitemid 34508081)
71. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC: Tuberculosis control and elimination 2010-50: Cure, care, and social development. Lancet 2010;375:1814-1829.
72. Young DB, Perkins MD, Duncan K, Barry CE 3rd: Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008;118:1255-1265. (Pubitemid 351500418)
73. Dye C, Williams BG: The population dynamics and control of tuberculosis. Science 2010;328:856-861.
74. Mwandumba HC, Bertel Squire S, White SA, Nyirenda MH, Kampondeni SD, Rhoades ER, Zijlstra EE, Molyneux ME, Russell DG: Association between sputum smear status and local immune responses at the site of disease in HIV-infected patients with pulmonary tuberculosis. Tuberculosis (Edinb) 2008;88:58-63. (Pubitemid 350284654)
75. Van Crevel R, Ottenhoff TH, Van der Meer JW: Innate immunity to mycobacterium tuberculosis. Clin Microbiol Rev 2002;15:294-309. (Pubitemid 34303767)
76. Lala S, Dheda K, Chang JS, Huggett JF, Kim LU, Johnson MA, Rook GA, Keshav S, Zumla A: The pathogen recognition sensor, nod2, is variably expressed in patients with pulmonary tuberculosis. BMC Infect Dis 2007;7:96.
77. Pan H, Dai Y, Tang S, Wang J: Polymorphisms of nod2 and the risk of tuberculosis: A validation study in the chinese population. Int J Immunogenet 2012;39:233-240.
78. Strober W, Murray PJ, Kitani A, Watanabe T: Signalling pathways and molecular interactions of nod1 and nod2. Nat Rev Immunol 2006;6:9-20. (Pubitemid 43279749)